Literature DB >> 16858189

Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy.

Stephen R Grobmyer1, Liang Wang, Mithat Gonen, Yuman Fong, David Klimstra, Michael D'Angelica, Ronald P DeMatteo, Larry Schwartz, Leslie H Blumgart, William R Jarnagin.   

Abstract

OBJECTIVE: To assess the value of preoperative imaging studies and the intraoperative assessment of perihepatic lymph nodes in patients undergoing partial hepatectomy for malignancy. SUMMARY BACKGROUND DATA: Perihepatic lymph node status is an important prognostic factor for patients undergoing hepatic resection for 1(o) and metastatic cancer. The value of preoperative imaging studies and intraoperative assessment of perihepatic nodes is unknown.
METHODS: Perihepatic lymph nodes were sampled in 100 patients undergoing resection for 1(o) and metastatic hepatic malignancy. At the time of sampling, participating surgeons assigned a clinical suspicion score (scale, 1-5: 1 = clinically negative, 5 = clinically positive). Preoperative CT scans and PET scans were reviewed in a blinded fashion by 2 radiologists. Clinical assessment, CT, and PET scan results were analyzed in the context of the pathologic status of the lymph nodes.
RESULTS: A mean of 3.2 +/- 0.2 nodes were sampled per patient. Fifteen patients had metastatic disease in perihepatic lymph nodes; 13 had suggestive findings on preoperative CT or PET, and 2 were clinically positive at exploration. Clinical assessment had a high negative predictive value (NPV) = 99% but a low positive predictive value (PPV) = 39%. Similarly, CT scans had a high NPV = 95% and a low PPV = 30%. PET scans had a NPV = 88% and a PPV of 100%. Of the 48 patients with both negative preoperative CT and PET scans, only 1 (2.1%) had metastatic nodal disease, and this was suspected based on the clinical assessment. Of the patients with negative CT and PET scans and a negative clinical assessment (n = 39), none had involved perihepatic nodes.
CONCLUSIONS: In patients with 1(o) and metastatic liver cancer, the incidence of truly occult metastatic disease to perihepatic lymph nodes is low. Routine sampling of perihepatic lymph nodes will therefore have a low yield in patients without some evidence of disease on preoperative CT or PET scans or at the time of exploration.

Entities:  

Mesh:

Year:  2006        PMID: 16858189      PMCID: PMC1602169          DOI: 10.1097/01.sla.0000217606.59625.9d

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  23 in total

1.  Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study.

Authors:  Daniel Jaeck; Hiroshi Nakano; Philippe Bachellier; Keiichiro Inoue; Jean-Christophe Weber; Elie Oussoultzoglou; Philippe Wolf; Marie-Pierre Chenard-Neu
Journal:  Ann Surg Oncol       Date:  2002-06       Impact factor: 5.344

Review 2.  Incidence, distribution, and significance of hilar lymph node metastases in hepatic colorectal metastases.

Authors:  Dominique M Elias; Jean-François Ouellet
Journal:  Surg Oncol Clin N Am       Date:  2003-01       Impact factor: 3.495

Review 3.  Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review.

Authors:  M S Rodgers; J L McCall
Journal:  Br J Surg       Date:  2000-09       Impact factor: 6.939

4.  Hepatic lymph node involvement in resected cases of liver metastases from colorectal cancer.

Authors:  N Kokudo; T Sato; M Seki; H Ohta; K Azekura; M Ueno; T Matsubara; A Yanagisawa; Y Kato; T Takahashi
Journal:  Dis Colon Rectum       Date:  1999-10       Impact factor: 4.585

Review 5.  The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies.

Authors:  Daniel Jaeck
Journal:  Ann Surg Oncol       Date:  2003-11       Impact factor: 5.344

6.  Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases.

Authors:  D Elias; J-F Ouellet; N Bellon; J-P Pignon; M Pocard; P Lasser
Journal:  Br J Surg       Date:  2003-05       Impact factor: 6.939

7.  Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival.

Authors:  D A August; P H Sugarbaker; R T Ottow; F J Gianola; P D Schneider
Journal:  Ann Surg       Date:  1985-02       Impact factor: 12.969

8.  Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis.

Authors:  Christophe Laurent; Antonio Sa Cunha; Eric Rullier; Denis Smith; Anne Rullier; Jean Saric
Journal:  J Am Coll Surg       Date:  2004-06       Impact factor: 6.113

9.  Intraoperative hepatic lymphatic mapping in patients with liver metastases from colorectal carcinoma.

Authors:  John M Kane; Morton S Kahlenberg; Miguel A Rodriguez-Bigas; John F Gibbs; Nicholas J Petrelli
Journal:  Am Surg       Date:  2002-09       Impact factor: 0.688

10.  The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy.

Authors:  Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Walter Franco Grigioni; Matteo Cescon; Andrea Gardini; Massimo Del Gaudio; Antonino Cavallari
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

View more
  28 in total

Review 1.  [Colorectal liver metastases. Neoadjuvant chemotherapy: aspects of medical and surgical oncology].

Authors:  Anke C Reinacher-Schick; W O Bechstein
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

2.  Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study.

Authors:  Xianwu Luo; Lei Yuan; Yi Wang; Ruiliang Ge; Yanfu Sun; Gongtian Wei
Journal:  J Gastrointest Surg       Date:  2014-01-07       Impact factor: 3.452

Review 3.  Lymphatics and colorectal liver metastases: the case for sentinel node mapping.

Authors:  Christopher Christophi; Linh Nguyen; Vijayaragavan Muralidharan; Mehrdad Nikfarjam; Jonathan Banting
Journal:  HPB (Oxford)       Date:  2013-07-19       Impact factor: 3.647

Review 4.  Surgical treatment for intrahepatic cholangiocarcinoma.

Authors:  Takahiro Uenishi; Takatsugu Yamamoto; Shigekazu Takemura; Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2014-02-15

Review 5.  The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics.

Authors:  Yuji Morine; Mitsuo Shimada
Journal:  J Gastroenterol       Date:  2015-04-02       Impact factor: 7.527

Review 6.  Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review.

Authors:  Neda Amini; Aslam Ejaz; Gaya Spolverato; Shishir K Maithel; Yuhree Kim; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2014-10-10       Impact factor: 3.452

Review 7.  Surgical outcomes of intrahepatic cholangiocarcinoma.

Authors:  Masakazu Yamamoto; Shun-ichi Ariizumi
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

8.  Cholangiocarcinoma: prognostic factors after surgical resection in China.

Authors:  Yue Wang; Helen Yang; Chunjian Shen; Ji Luo
Journal:  Int J Clin Exp Med       Date:  2015-04-15

9.  The outcome of liver resection and lymphadenectomy for hilar lymph node involvement in colorectal cancer liver metastases.

Authors:  Wei Liu; Xiao-Luan Yan; Kun Wang; Quan Bao; Yi Sun; Bao-Cai Xing
Journal:  Int J Colorectal Dis       Date:  2014-04-18       Impact factor: 2.571

Review 10.  Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignancies.

Authors:  Long Sun; Hua Wu; Yong-Song Guan
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.